This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Aaron J. Schohn
Associate
San Francisco +1 415 591 7010 aschohn@cov.com Download V-card

Aaron Schohn counsels pharmaceutical, medical device, diagnostics and other life sciences companies in technology licensing and transfers, research, development and commercialization collaborations, supply and distribution agreements and other strategic commercial agreements. Mr. Schohn represents life sciences companies at all stages of development on complex issues from global collaborative relationships to daily commercial and operational matters.

  • Represented Alcon, the eye care division of Novartis, in a major collaboration with Google to develop and commercialize a glucose sensing contact lens for use by diabetic patients and an accommodating intraocular and contact lenses to restore the eye’s autofocus.
  • Represented Astellas Pharma Inc. in major transactions, including its:
    • collaboration with Mitokyne to discover and develop drugs targeting mitochondria-related diseases, with Mitokyne leading the R&D activities and Astellas assuming all clinical development and commercial activities, including an option that allows for the future acquisition of Mitokyne by Astellas on pre-determined terms at the end of the collaboration period; and
    • collaboration with Potenza Therapeutics to develop immune-oncology therapeutics, with Potenza leading the R&D activities and Astellas assuming all clinical development and commercial activities, including an option that allows for the future acquisition of Potenza by Astellas on pre-determined terms at the end of the collaboration period.

Memberships and Affiliations

  • Access4Bikes (a Marin, CA based mountain bike advocacy non-profit), Board Member

Previous Experience

  • Mr. Schohn was an associate in the life sciences transactional practices of two different international law firms from 2008-2016.